COMMUNIQUÉS West-GlobeNewswire

Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
09/10/2025
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today [...]
Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
09/10/2025
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in cognition and behavior at 2 years; results contrast with minimal change in natural [...]
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
09/10/2025
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability 1 through 2027, independent of Star ratings [...]
VitalHub Announces Novari Health Deployment in the UK
09/10/2025
TORONTO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced that Novari Health (“Novari”), a VitalHub company, has been commissioned for its first UK [...]
Palisade Bio Announces Cancellation of Special Meeting of Stockholders
09/10/2025
Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients [...]
Portsmouth Square, Inc. Announces FY2025 Results; Going-Concern Doubt Alleviated Following March 2025 Hotel Refinancing and Strong Operating Trends
09/10/2025
Los Angeles, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Portsmouth Square, Inc. ("Portsmouth" or the "Company") (OTC: PRSI) reported results for the fiscal year ended June 30, 2025 and announced that the substantial doubt [...]
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
09/10/2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market [...]
CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience
09/10/2025
Ohio-born cannabis brand brings personal story, community focus, and premium products to Silver Drive location COLUMBUS, Ohio, Oct. 09, 2025 (GLOBE NEWSWIRE) -- CERTIFIED , a family-owned, vertically integrated Ohio [...]
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
09/10/2025
The Center Certification Ceremony took place during the ICPO Reception on the occasion of the EANM conference on Oct 4, 2025, in Barcelona. October 9, 2025 – Wiesbaden, Germany. The International Centers for Precision [...]
Idorsia launches an offering of registered shares – to fund the company to overall profitability
09/10/2025
Ad hoc announcement pursuant to Art. 53 LR NOT FOR RELEASE, PUBLICATION, DISTRIBUTION IN OR INTO THE UNITED STATES, ITALY, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR [...]
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
09/10/2025
Announcement no. 09/2025 Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has today informed the Coloplast [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025
09/10/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
09/10/2025
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
09/10/2025
– Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory patients; all three patients remained off immunomodulators since infusion and [...]
JOURTHON® Launches Brain Health Softgel
09/10/2025
NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Memory lapses, poor concentration, and mental fatigue are no longer just signs of aging. Today, they affect professionals, entrepreneurs, and parents across all stages of life [...]
Childhood Cancer Deserves Year-Round Commitment to Funding and Research
09/10/2025
Mothers channel loss into a $1.5 million commitment to fund childhood cancer research. HOUSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Five mothers who each lost a child to Ewing sarcoma, an aggressive pediatric cancer, have [...]
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
09/10/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT) [...]
Academy Award-Winning Actress Helen Hunt to Headline Methodist Healthcare Foundation Luncheon
09/10/2025
Memphis, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- The Methodist Healthcare Foundation will welcome Academy Award-winning actress and breast cancer advocate Helen Hunt as the featured speaker for its annual Luncheon on [...]
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
09/10/2025
KNOXVILLE, Tenn., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the publication of independent preclinical research by Aru Narendran, [...]

Pages